Abstract OBJECTIVES: To assess safety and effectiveness of symmetric and asymmetric occluders in perventricular device closure without cardiopulmonary bypass of perimembranous ventricular septal defects (pmVSDs).
INTRODUCTION
Perimembranous ventricular septal defects (pmVSDs) account for about 80% of isolated VSDs, by far the most common form of congenital heart disease [1, 2] . Although widely accepted as conventional treatment for pmVSDs [3] , surgical closure with cardiopulmonary bypass is associated with large trauma and long recovery time [4] , and transcatheter closure, a proven effective alternative [5] , is technically challenging and might affect the tricuspid and aortic valves and conduction system [6] . In recent years and based on safety and efficacy outcomes at mid-term followup, minimally invasive perventricular device occlusion without cardiopulmonary bypass has emerged as a treatment option for pmVSDs [7] [8] [9] [10] [11] [12] . Although a few studies [10, [12] [13] [14] have mentioned use of asymmetric occluders for pmVSDs with a short defect-to-aortic valve rim, there are scarce comparative safety and efficacy data on use of symmetric and asymmetric occluders for perventricular device closure of pmVSDs, which is the subject of the present retrospective, single-centre study with mid-term follow-up.
MATERIALS AND METHODS

Patients
We conducted a retrospective review of data from all patients who underwent minimally invasive perventricular device closure without cardiopulmonary bypass guided by transoesophageal echocardiography (TEE) at Fuwai Hospital from May 2011 to April 2016. Before procedures, all patients underwent physical examination, chest radiography, transthoracic echocardiography and electrocardiography. The indications for pmVSDs device closure were [7] (i) age 6 months or greater and weight 4 kg or greater; (ii) clinical manifestations: symptoms of heart failure, recurrent respiratory infection, developmental delay or history of bacterial endocarditis; and (iii) transthoracic echocardiographic assessment: diameter of pmVSD is >3 mm and <10 mm; no aortic valve prolapse; and no pathological aortic regurgitation. The exclusion criteria were (i) predominant right-to-left shunt, (ii) more than mild aortic regurgitation and (iii) active infective endocarditis.
The study protocol was approved by the Institutional Ethics Committee of Fuwai Hospital. All patients or their legal guardians provided their informed consent to perform the procedure and use their clinical records.
Devices and delivery system
The pmVSD occluder (Shanghai Shape Memory Alloy Co., Ltd, 47 Dalin Road, Huangpu, Shanghai, China) and its delivery system have been described in detail previously [7] . Briefly, the occluder is a self-expandable, double-disk device that contains a 0.005-inch nitinol wire mesh and fabric, and has a waist height of 4 mm, which is close to the interventricular septum thickness. The symmetric occluder is 2 mm larger than the waist in both the left and right ventricular disk. The asymmetric occluder's left ventricular disk is partially edgeless and 6 mm larger than the waist with a platinum marker at one end (Fig. 1) . According to occluder size, which was 1-2 mm larger than pmVSD diameter, the occluder was delivered using a 6-9 Fr sheath. Symmetric and asymmetric occluders were used according to TEE-measured defect-to-aortic valve rim > _2 and <2 mm, respectively. Generally, if aortic regurgitation developed with a symmetric occluder, then an asymmetric occluder was tried. If aortic regurgitation persisted, the case was converted to conventional surgical closure.
Procedures
After general anaesthesia with endotracheal intubation, patients were placed in supine position in an operating room. The procedure was performed entirely under TEE guidance. TEE was performed intraoperatively to confirm the size, location of pmVSDs and the rim between the defect and aortic valve. Symmetric and asymmetric occluders were selected according to TEE-measured defect-to-aortic valve rim > _2 and <2 mm, respectively. Heparin (80 IU/kg) and antibiotics were administered intravenously preprocedure.
A 1-2 cm modified left fourth parasternal intercostal incision or a 2-cm inferior median sternotomy was made. After opening and suspending the pericardium, the free wall of the right ventricle was exposed. A purse-string suture was placed on the vessel-free region of the right ventricular free wall. A trocar was punctured to right ventricular cavity within the purse-string. A 0.035-inch guide wire was passed through pmVSDs by the trocar. After the trocar was removed, a delivery sheath was advanced through the pmVSDs to the left ventricle along the guide wire. After removing the guide wire and dilator sheath, a selected occluder was deployed through the delivery sheath under TEE guidance. Symmetric and asymmetric occluders were released using the four-chamber view and the long axis view of the aorta, respectively. The 'push-pull' test was performed to verify that the occluder straddled the defect stably. The shape and position of the occluder, residual shunt and valvular regurgitation (especially for aortic valve) then were reassessed by TEE (Fig. 2 ). In the case of complete atrioventricular block (CAVB), residual shunt >2 mm, new aortic regurgitation or more than mild tricuspid regurgitation, patients were converted to surgical treatment with cardiopulmonary bypass. Finally, the delivery sheath was pulled out, and the purse-string suture was tied tightly. A pericardium drainage tube was inserted if making an inferior median sternotomy. After closing the incision, all patients were sent to the intensive care unit where the endotracheal tube was removed. Transthoracic echocardiography and electrocardiography were performed within 24 h post-procedure.
Follow-up
For post-procedure anticoagulation, aspirin tablet (3-5 mg/kg body weight) was administered daily for 6 months. Outpatient assessment with transthoracic echocardiography and electrocardiography was performed at 1, 3, 6 and 12 months, and yearly thereafter.
Statistical analyses
All continuous variables are expressed as means ± standard deviation and ranges and were compared using the Student's t-test, whereas categorical variables are expressed as frequencies and percentages and were compared using the Chi-square test. SPSS 20.0 for Windows (SPSS Inc., Chicago) was used for statistical analysis. 
RESULTS
A total of 581 consecutive patients with pmVSDs aged 6 months-37 years (3.7 ± 3.1 years) and weighing 6.1-71 kg (16.3 ± 8.3 kg) were enrolled for perventricular device closure (Table 1 and Fig. 3 ). The success rate of device implantation was 92.6% (538/581). Forty-three cases were converted to conventional surgical repair immediately (Table 2) : 25 with residual shunts >2 mm wide; 16 with new aortic regurgitation even with an asymmetric occluder; and two with CAVB.
According to occluder type used, the 538 patients with successful device closure deployment were divided into symmetric (n = 353) and asymmetric (n = 185) groups. The baseline characteristics of the two groups are presented in Table 3 . There were no significant between-group differences in terms of gender, age, body weight, defect diameter or occluder diameter. However, the symmetric group had lower trivial residual shunt rate [5.7% (20/353) vs 11.4% (21/185), P = 0.018] and bundle branch block rate [0.8% (3/353) vs 5.4% (10/185), P = 0.002] than the asymmetric group before discharge. One patient with asymmetric occluder experienced an intermittent CAVB on the fourth day after procedure, and sinus rhythm was restored after a 5-day course of corticosteroid therapy. Most patients were discharged within 4 days after the operation.
There were no deaths during the hospital stay or follow-up period. Follow-up duration ranged from 1 to 60 months (28.6 ± 21.2 months) and revealed no severe complications such as aortic regurgitation, malignant arrhythmias, haemolysis or device dislocation. However, at follow-up, the asymmetric group continued to have higher trivial residual shunt rate [5.9% (11/ 185) vs 0.8% (3/353), P = 0.001] and bundle branch block rate [3.8% (7/185) vs 0.6% (2/353), P = 0.009] than the symmetric group. The asymmetric group had lower disappearance rate of residual shunt [47.6% (10/21) vs 85.0% (17/20), P = 0.020] and similar disappearance rate of branch block rate [30.0% (3/10) vs 33.3% (1/3), P = 1.000] than the symmetric group.
DISCUSSION
Developed as a treatment option for selected patients, perventricular device closure of pmVSDs is widely used in China and some European countries [1, 7, 8, 10, 14] . It has the advantages of no cardiopulmonary bypass and less surgical trauma relative to the gold standard of conventional surgical closure, and of no radiation, procedural ease and vascular complication avoidance relative to percutaneous device occlusion. To avoid the impact of devices on aortic valve, new modified devices have been introduced such as asymmetric occluders which were designed for use in patients with a short rim between the defect and the aortic valves [13] . In this study, use of symmetric and asymmetric occluders in the hybrid technique appeared safe and efficacious during a mean 28.6-month follow-up period. However, both during hospital stay and follow-up, the patients with asymmetric occluders had a lower residual shunt disappearance rate and a higher branch block incidence rate than those with symmetric occluders, which would favour more proactive conversion to surgical repair in the presence of residual shunt in patients who received an asymmetric occluder; it provided useful evidence for doctors to decide whether or not to immediately switch to conventional surgery intraoperatively, which was the focus of attention on perventricular device closure of pmVSDs. Residual shunt, a common complication with an incidence of about 2.1-13% at discharge after perventricular device closure [4, 7, 10, 14] , may cause haemolysis and affect occluder stability [15] , which in turn may lead to surgical removal of occluders. In this study, patients were converted to conventional surgical repair if any shunt >2 mm was identified by TEE. Because the left ventricular disk of the asymmetric occluder was partially edgeless, blood could flow more readily than in the case of a symmetric occluder through the gap between the subaortic valve and occluder. Therefore, the incidence of residual shunt was higher and more unlikely to disappear in the asymmetric group in this study.
Arrhythmia is another complication of pmVSDs device closure, with CAVB being the most serious [16] . In previous studies, CAVB incidence ranged from 0.6% to 20% developing immediately, or days or even years after operation [7, 17, 18] . Although the exact mechanism of CAVB remains speculative, proposed contributing factors include mechanical compression, progressive device flattening, friction of the device disk on the septal myocardium and inflammatory response [17, 19] . Likely because we used occluders with a waist height of 4 mm and waist diameter 1-2 mm greater than pmVSD diameter to decrease compression of tissues around the pmVSDs, only one patient experienced intermittent CAVB on the fourth day after the operation, and sinus rhythm was restored after 5 days of corticosteroid therapy. However, because the left ventricular disk was 6 mm larger than the waist with a platinum Data are presented as n (%) or mean (range). CAVB: complete atrioventricular block. Data are presented as n (%) or mean (range).
marker at one end, the asymmetric occluder was more prone to compress the conductive tissue around the pmVSDs, possibly leading to bundle branch block, which may account for the higher incidence of branch block in the asymmetric group in this study. Moreover, similar branch block disappearance rate between groups indicated that it was difficult to recover once the occluder had compressed the conduction system. Device-induced aortic regurgitation is also a severe complication of pmVSD device closure [20] because of the close proximity of some pmVSDs to the aortic valve. Although an asymmetric occluder minimizes aortic valve interference, its release requires more skills to achieve proper positioning and use of the long axis view of the aorta to clearly assess the relationship between the aortic valve and the occluder under TEE. The occluder needs to be rotated to keep the mark of the long edge away from the aortic valve after release of the left ventricular disk. The presence of any new aortic regurgitation regardless of degree reflects an untoward effect of the occluder on aortic valve function, as seen in 16 patients in this study who were converted to conventional surgical closure.
Although we preliminary screened patients for suitability to undergo perventricular device closure by transthoracic echocardiography and confirmed again by TEE, 43 cases were immediately converted to conventional surgical repair because of residual shunt, aortic regurgitation and CAVB. Use of 3D technique and manufacturing personalized occluders according to VSD shape might help to reduce conversion and complications.
Study limitations
This study is limited by its retrospective, single-centre design, and therefore does not capture the multiplicity of clinical practice and patient populations. In addition, study mean follow-up time was 28.6 months with a wide range, and longer and more consistent follow-up is warranted to verify the residual shunt and late heart block results.
CONCLUSIONS
Perventricular device closure of pmVSDs appears safe and effective with symmetric and asymmetric occluders. However, the lower residual shunt disappearance and higher branch block incidence rates for asymmetric occluders would favour more proactive conversion to surgical repair immediately when residual shunt is present intraoperatively. 
